About Us
Every year, more than a million people across the world are killed due to syringe reuse and unsafe injection practices in healthcare facilities. ApiJect was founded to stop this tragedy.
Advancing Fill-Finish to Solve Drug Delivery Challenges for the World
Marc Koska, OBE, recognized that to address the problem of unsafe medical injections, the world needed a single-use prefilled syringe that could work in any market, and that Blow-Fill-Seal was the key to making that possible.
What he created was more than just a scalable and efficient prototype prefilled injector for global health. It was a new drug delivery platform with the potential to enable more liquid medicines and vaccines to safely reach more patients across the world.
Today, ApiJect Systems is a medical technology company working to improve how sterile liquid medicines and vaccines are fill-finished across the world.
We do this by helping pharmaceutical companies design rapidly-scalable, cost-efficient drug delivery systems, and then assist in manufacturing those devices.
Our mission is to make injectable medicines and vaccines safe and accessible to everyone.
Shorter Lead Times
Instead of a 49-step supply chain process, with the ApiJect Single-Dose Prefilled Injector, we have a 12-step supply chain process to aseptically fill-finish your drug or vaccine.
Safety
Prefilled injection formats avoid costly dosing errors and save dose administration time in emergency room situations vs. vials & syringes. According to the NIH, 7,000-9,000 patients die each year due to medication errors.
Lower Manufacturing Costs
Reduce raw material costs for plastic, combined with a more efficient manufacturing process allows ApiJect to provide prefilled formats at the same cost of a single use vial & syringe.
Lower Carbon Footprint
Plastic entails less manufacturing material, less energy usage, fewer transportation steps, less weight in shipping vs. glass.